Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol])

Joel A. Vilensky, Wendy M. Robertson, Sid Gilman

Research output: Contribution to journalShort survey

11 Citations (Scopus)

Abstract

In 1951 Denny-Brown and Porter described the successful treatment of Wilson's disease using the chelating agent British antilewisite. The presentation of their results both at meetings and in print changed the traditional view of neurology from a descriptive to an interventional discipline using treatments based on the underlying biochemical disorder. The authors review the importance of these reports and provide edited digital versions of the films Denny-Brown made of the five patients described in the initial reports.

Original languageEnglish (US)
Pages (from-to)914-916
Number of pages3
JournalNeurology
Volume59
Issue number6
DOIs
StatePublished - Sep 24 2002

Fingerprint

Dimercaprol
Hepatolenticular Degeneration
Neurology
Chelating Agents
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]). / Vilensky, Joel A.; Robertson, Wendy M.; Gilman, Sid.

In: Neurology, Vol. 59, No. 6, 24.09.2002, p. 914-916.

Research output: Contribution to journalShort survey

Vilensky, Joel A. ; Robertson, Wendy M. ; Gilman, Sid. / Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]). In: Neurology. 2002 ; Vol. 59, No. 6. pp. 914-916.
@article{3b5df8e900a8480ebb22daf58dc5ecfa,
title = "Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol])",
abstract = "In 1951 Denny-Brown and Porter described the successful treatment of Wilson's disease using the chelating agent British antilewisite. The presentation of their results both at meetings and in print changed the traditional view of neurology from a descriptive to an interventional discipline using treatments based on the underlying biochemical disorder. The authors review the importance of these reports and provide edited digital versions of the films Denny-Brown made of the five patients described in the initial reports.",
author = "Vilensky, {Joel A.} and Robertson, {Wendy M.} and Sid Gilman",
year = "2002",
month = "9",
day = "24",
doi = "10.1212/WNL.59.6.914",
language = "English (US)",
volume = "59",
pages = "914--916",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol])

AU - Vilensky, Joel A.

AU - Robertson, Wendy M.

AU - Gilman, Sid

PY - 2002/9/24

Y1 - 2002/9/24

N2 - In 1951 Denny-Brown and Porter described the successful treatment of Wilson's disease using the chelating agent British antilewisite. The presentation of their results both at meetings and in print changed the traditional view of neurology from a descriptive to an interventional discipline using treatments based on the underlying biochemical disorder. The authors review the importance of these reports and provide edited digital versions of the films Denny-Brown made of the five patients described in the initial reports.

AB - In 1951 Denny-Brown and Porter described the successful treatment of Wilson's disease using the chelating agent British antilewisite. The presentation of their results both at meetings and in print changed the traditional view of neurology from a descriptive to an interventional discipline using treatments based on the underlying biochemical disorder. The authors review the importance of these reports and provide edited digital versions of the films Denny-Brown made of the five patients described in the initial reports.

UR - http://www.scopus.com/inward/record.url?scp=0037167539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037167539&partnerID=8YFLogxK

U2 - 10.1212/WNL.59.6.914

DO - 10.1212/WNL.59.6.914

M3 - Short survey

C2 - 12297577

AN - SCOPUS:0037167539

VL - 59

SP - 914

EP - 916

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -